Medicare Enrolled
Dr. Evan Appelbaum, M.D.
Cardiovascular Disease · Chestnut Hill, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Appelbaum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Appelbaum?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Appelbaum
Dr. Evan Appelbaum is a cardiovascular disease specialist in Chestnut Hill, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Appelbaum performed 338,864 Medicare services across 3,720 unique beneficiaries.
Between the years covered by Open Payments, Dr. Appelbaum received a total of $49,235 from 38 pharmaceutical and/or device companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Appelbaum is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in MA
$49,235 industry payments
Medicare Practice Summary
Medicare Utilization ↗338,864
Medicare services
Top 0% in MA for cardiovascular disease
3,720
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~17,835 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone undecanoate injection (Aveed) An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection. |
208,500 | $1 | $3 |
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
123,535 | $0 | $0 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
1,067 | $70 | $210 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
972 | $103 | $326 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
772 | $12 | $57 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
521 | $67 | $255 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
389 | $25 | $83 |
| Total estradiol level test A blood test that measures the total amount of estradiol, a form of estrogen, in the body. |
373 | $27 | $96 |
| Sex hormone binding globulin level test A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream. |
370 | $21 | $75 |
| Luteinizing hormone level test A blood test that measures the level of luteinizing hormone, a reproductive hormone. This test helps evaluate hormonal balance and reproductive function. |
359 | $18 | $72 |
| PSA test (prostate cancer screening) | 340 | $18 | $72 |
| Follicle stimulating hormone (FSH) level A blood test to measure the level of follicle stimulating hormone, a reproductive hormone. |
339 | $18 | $77 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
280 | $12 | $63 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
183 | $83 | $280 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
153 | $160 | $500 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
89 | $165 | $525 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
89 | $128 | $381 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
69 | $55 | $227 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
58 | $157 | $429 |
| Prolactin level test A blood test that measures the amount of prolactin, a hormone produced by the pituitary gland that stimulates milk production, in the body. |
50 | $19 | $64 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
47 | $16 | $57 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
46 | $9 | $35 |
| Progesterone level test A blood test that measures the amount of progesterone, a reproductive hormone, in your body. |
43 | $20 | $72 |
| Dehydroepiandrosterone (DHEA) hormone level test This test measures the level of dehydroepiandrosterone (DHEA) hormone in the blood. DHEA is a hormone produced by the adrenal glands. |
40 | $25 | $80 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
23 | $43 | $201 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
21 | $10 | $47 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
21 | $71 | $250 |
| Ultrasound of penis artery and vein blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins of the penis. |
19 | $99 | $352 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
19 | $81 | $234 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
17 | $10 | $64 |
| Ambulatory blood pressure monitoring, 1 day or longer This procedure involves wearing a device to record blood pressure over a day or longer. It includes analyzing the data, interpreting the results, and providing a report. |
17 | $38 | $114 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
16 | $37 | $84 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
14 | $18 | $65 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $87 | $259 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$49,235
Total received (2018-2024)
Avg $7,034/year across 7 years
Top 10% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
266
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,350 (88.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,885 (12.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,667
2023
$1,120
2022
$1,001
2021
$863
2020
$377
2019
$29,767
2018
$14,440
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Antares Pharma, Inc.
$389
Amgen Inc.
$183
PFIZER INC.
$176
Novo Nordisk Inc
$159
E.R. Squibb & Sons, L.L.C.
$145
Novartis Pharmaceuticals Corporation
$133
Esperion Therapeutics, Inc.
$99
Tolmar, Inc.
$88
Endo USA, Inc.
$76
Janssen Pharmaceuticals, Inc
$57
Lilly USA, LLC
$54
Endo Pharmaceuticals Inc.
$49
HEARTFLOW, INC.
$35
Kiniksa Pharmaceuticals International, plc
$24
Top 3 companies account for 44.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca UK Limited
$43,350
Amgen Inc.
$1,103
Antares Pharma, Inc.
$877
PFIZER INC.
$512
Endo Pharmaceuticals Inc.
$458
Janssen Pharmaceuticals, Inc
$331
Novo Nordisk Inc
$311
Esperion Therapeutics, Inc.
$270
Tolmar, Inc.
$168
UROVANT SCIENCES INC
$166
Supernus Pharmaceuticals, Inc.
$165
E.R. Squibb & Sons, L.L.C.
$159
Metuchen Pharmaceuticals
$151
Astellas Pharma US Inc
$146
Novartis Pharmaceuticals Corporation
$133
HeartFlow, Inc.
$107
Acerus Pharmaceuticals Corporation
$90
Endo USA, Inc.
$76
GE HealthCare
$70
Medtronic Vascular, Inc.
$69
Aytu BioScience, Inc
$56
Lilly USA, LLC
$54
Kiniksa Pharmaceuticals, Ltd.
$47
Bardy Diagnostics, Inc.
$40
HEARTFLOW, INC.
$35
Medtronic, Inc.
$28
Aytu Bioscience, Inc
$27
Sun Pharmaceutical Industries Inc.
$26
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$26
Baxter Healthcare
$25
Bayer Healthcare Pharmaceuticals Inc.
$25
Boston Scientific Corporation
$24
Kiniksa Pharmaceuticals International, plc
$24
AbbVie, Inc.
$24
Janssen Scientific Affairs, LLC
$16
BOSTON SCIENTIFIC CORPORATION
$16
AstraZeneca Pharmaceuticals LP
$16
Avadel Specialty Pharmaceuticals, LLC
$15
Top 3 companies account for 92.1% of all-time payments
Associated products mentioned in payments ›
AMS · AVEED · Androgel · Arcalyst · CAMZYOS · CHANTIX · Carnation Ambulatory Monitor · Corlanor · ELIGARD · ELIQUIS · Erleada · FARXIGA · FFRct · GEMTESA · GENERAL BPH · Hillrom - Carnation Ambulatory Monitor · JARDIANCE · JATENZO · Kerendia · LEQVIO · LifeVest · MYRBETRIQ · Myrbetriq · NEXLETOL · NOCDURNA · NURTEC ODT · Natesto · Noctiva · ONGLYZA · OTREXUP · Otrexup · Ozempic · REVEAL LINQ · Repatha · Reveal LINQ · Saxenda · Stendra · TLANDO · Wegovy · XARELTO · XIAFLEX · XYOSTED · YONSA · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for cardiovascular disease in MA.
Geographic Context
Cardiologists within 10 mi
582
Per 100K population
80.3
County median income
$126,497
Nearest hospital
BOURNEWOOD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Appelbaum is a mixed practice specialist, with above-average Medicare volume (top 0% in MA), with consulting-driven industry engagement in the top 10% of MA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Appelbaum experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Appelbaum performed 208,500 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Appelbaum receive payments from pharmaceutical companies?
Yes. Dr. Appelbaum received a total of $49,235 from 38 companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Appelbaum's costs compare to other cardiologists in Chestnut Hill?
Dr. Appelbaum's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Appelbaum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Chestnut Hill
Browse cardiologists in Chestnut Hill ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MA
Which MA cardiologists receive the most from drug and device companies.
By company
AstraZeneca UK Limited Payments to Doctors
See all physicians who received payments from AstraZeneca UK Limited.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Antares Pharma, Inc. Payments to Doctors
See all physicians who received payments from Antares Pharma, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology